Interestingly, while WASL expression was not altered in MDMs (p = .89), we detected lower expression levels of this gene in microglia of IDH WT gliomas in comparison to microglia from non‐tumor samples (Figure 4c). This evidence concerns the gene WASL and central nervous system cancer.